Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma
Rachel Lorenc, Roni Shouval, Jessica Flynn, Sean M. Devlin, Amethyst Saldia, Alejandro Luna, Magdalena Corona, Ana Alarcón Tomás, Giulio Cassanello, Lori A. Leslie, Kai Rejeski, Richard J. Lin, Michael Scordo, Gunjan L. Shah, M. Lia Palomba, Gilles Salles, Jae H. Park, Sergio Giralt, Miguel‐Angel Perales, Andrew Ip, Parastoo B. Dahi
Topics & Concepts
Chimeric antigen receptorLymphomaCD19AntigenMedicineCancer researchImmunologyVirologyImmunotherapyImmune systemCAR-T cell therapy researchLymphoma Diagnosis and Treatment